BOULDER, Colo., Jan. 30, 2023 /PRNewswire/ — Proov, a diagnostics company offering medical grade at-home tests and a support platform, is announcing today that it has received patent issue notification for its fourth utility patent. The patent covers progesterone (or PdG) testing via…
Related Articles
BioMed Dropped $625M On A Big Boulder Bet. Here’s How Leasing Is Looking
In just over two years since BioMed Realty acquired the 1M SF Flatiron business park in Boulder, Colorado, leasing has fallen flat, with just 50K SF of life sciences tenants signed this year. The life sciences-focused […]
Nation’s first government-licensed psychedelic facilitator training expands to Colorado, propelling psychedelic healthcare movement
InnerTrek now accepting applications for Colorado’s first training program, which is available virtually to students worldwide BOULDER, Colo., Dec. 3, 2024 /PRNewswire/ — InnerTrek, an Oregon-based psilocybin facilitator training program, is now licensed by Colorado’s […]
Foresight Diagnostics Expands Series B Financing to $73.75 Million to Advance the Foresight CLARITY™ MRD Platform
BOULDER, Colo., July 30, 2024 (GLOBE NEWSWIRE) — Foresight Diagnostics, Inc. (“Foresight”), a leading diagnostics company specializing in the development of ultra-sensitive minimal residual disease (MRD) detection, today announced the closing of $33 million in […]
